Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitsugu Aoki

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Molecular Therapy. Nucleic Acids|October 9, 2024
Allele-specific CRISPR-Cas9 editing inactivates a single-nucleotide variant associated with collagen VI muscular dystrophyYoshitsugu Aoki
Developmental Medicine and Child Neurology|January 30, 2026
Making brain health routine in Duchenne muscular dystrophy: What the BIND screener adds-and what it is not designed to doYoshitsugu Aoki
Journal of Stem Cells & Regenerative Medicine|June 27, 2023
Mr. Takashi Onaka Memorial Oration: I. Updates on solutions to DMDYoshitsugu Aoki
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Neurological Behavioral Assessment of Exon-Skipping Therapy for Neuromuscular Disorders Using Displaced Object Recognition Test, Open Field Test, and Three-Chamber Social Approach TestHiroya Ono, Yoshitsugu Aoki
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Electrophysiological Evaluation in mdx52 Mouse Brain After Antisense-Mediated Exon 51 or 53 SkippingYasumasa Hashimoto, Yoshitsugu Aoki
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Splice Modulation Studies Using Urine-Derived CellsKatsuhiko Kunitake, Yoshitsugu Aoki
The Journal of Pathology|July 20, 2019
Autoimmune response and its long-term consequences after exon-skipping therapy in a Duchenne muscular dystrophy mouse modelJoel Z Nordin, Yoshitsugu Aoki
Experimental Animals|June 17, 2021
Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in JapanMutsuki Kuraoka, Yoshitsugu Aoki, Shin'ichi Takeda
Frontiers in Physiology|March 25, 2022
Editorial: Challenges and Opportunities for Neuromuscular Disease Modelling Using Urine-derived Stem CellsChaitra Sathyaprakash, Katsuhiko Kunitake, Yoshitsugu Aoki
Journal of Visualized Experiments : Jove|May 26, 2020
Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived CellsHotake Takizawa, Mitsuto Sato, Yoshitsugu Aoki
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Molecular Therapy. Nucleic Acids|October 9, 2024
Allele-specific CRISPR-Cas9 editing inactivates a single-nucleotide variant associated with collagen VI muscular dystrophyYoshitsugu Aoki
Developmental Medicine and Child Neurology|January 30, 2026
Making brain health routine in Duchenne muscular dystrophy: What the BIND screener adds-and what it is not designed to doYoshitsugu Aoki
Journal of Stem Cells & Regenerative Medicine|June 27, 2023
Mr. Takashi Onaka Memorial Oration: I. Updates on solutions to DMDYoshitsugu Aoki
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Neurological Behavioral Assessment of Exon-Skipping Therapy for Neuromuscular Disorders Using Displaced Object Recognition Test, Open Field Test, and Three-Chamber Social Approach TestHiroya Ono, Yoshitsugu Aoki
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Electrophysiological Evaluation in mdx52 Mouse Brain After Antisense-Mediated Exon 51 or 53 SkippingYasumasa Hashimoto, Yoshitsugu Aoki
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Splice Modulation Studies Using Urine-Derived CellsKatsuhiko Kunitake, Yoshitsugu Aoki
The Journal of Pathology|July 20, 2019
Autoimmune response and its long-term consequences after exon-skipping therapy in a Duchenne muscular dystrophy mouse modelJoel Z Nordin, Yoshitsugu Aoki
Experimental Animals|June 17, 2021
Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in JapanMutsuki Kuraoka, Yoshitsugu Aoki, Shin'ichi Takeda
Frontiers in Physiology|March 25, 2022
Editorial: Challenges and Opportunities for Neuromuscular Disease Modelling Using Urine-derived Stem CellsChaitra Sathyaprakash, Katsuhiko Kunitake, Yoshitsugu Aoki
Journal of Visualized Experiments : Jove|May 26, 2020
Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived CellsHotake Takizawa, Mitsuto Sato, Yoshitsugu Aoki
Pageof 13